NCT05569356NOT_YET_RECRUITINGanonymous

Biomarkers of Inflammation and Autoimmunity: Diagnostic Contribution, Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy.

Sponsor

Source record

Assistance Publique - Hôpitaux de Paris

Phase

Source record

Not classified

Modality

AI-normalized

protein therapy

Target

AI-normalized

Prospective, Retrospective

Indication / condition

AI-normalized

Arrhythmogenic Cardiomyopathy

Intervention

Source record

Prospective, Retrospective

Related intelligence directories

Indication directory: Arrhythmogenic Cardiomyopathy Modality directory: protein therapy Target directory: Prospective

Source & freshness

Source record

NCT ID

NCT05569356

Original source

ClinicalTrials.gov

Source last updated

Oct 13, 2022

Ingested at

Jun 11, 2026

Internal sync

Jun 11, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT05569356

Title

Biomarkers of Inflammation and Autoimmunity: Diagnostic Contribution, Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy.

Sponsor

Assistance Publique - Hôpitaux de Paris

Status

NOT_YET_RECRUITING

Phase

Detailed source ingestion pending

Condition raw

Arrhythmogenic Cardiomyopathy

Condition normalized

Arrhythmogenic Cardiomyopathy

Modality raw

protein therapy

Modality normalized

protein therapy

Target raw

Prospective, Retrospective

Target normalized

Prospective, Retrospective

Interventions

Prospective, Retrospective

Public preview

Source record

This study aims to identify novel inflammatory biomarkers in AC, whether in circulating blood, in situ or as imaging biomarkers to better understand the pathophysiology of the disease and then to determine contribution to the clinical management of patients.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Biomarkers of Inflammation and Autoimmunity: Diagnostic Contribution, Prognosis and Physiopathological Aspects in Arrhythmogenic Cardiomyopathy.

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 20, 2026

NCT ID

NCT05569356

Status

NOT_YET_RECRUITING

Phase

N/A

Sponsor

Assistance Publique - Hôpitaux de Paris

Executive brief

Investment-Ready Snapshot

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedOct 13, 2022

Internal syncJun 11, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT05569356

Indication

Arrhythmogenic Cardiomyopathy

Modality

protein therapy

Target

Prospective, Retrospective

Intervention

Prospective, Retrospective

Source record